Evidence map›Paper›PMID 39425634›Full record

ReviewInternal medicine journal2024

Phenotype of patients with late diagnosis of 22q11 deletion: a review and retrospective study.

Marissa Loh, Tamar Schildkraut, Angela Byrnes, Nikki Gelfand, Lucy Gugasyan, Ari E Horton, Matthew F Hunter, Samar Ojaimi

Abstract readReview
In one paragraph

Review in Internal medicine journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marissa LohPaediatrics, Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.
Tamar SchildkrautSchool of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
Angela ByrnesMonash Genetics, Monash Health, Melbourne, Victoria, Australia.
Nikki GelfandMonash Genetics, Monash Health, Melbourne, Victoria, Australia.
Lucy GugasyanCytogenetics Laboratory, Monash Health, Melbourne, Victoria, Australia.
Ari E HortonMonash Genetics, Monash Health, Melbourne, Victoria, Australia.
Matthew F HunterMonash Genetics, Monash Health, Melbourne, Victoria, Australia.
Samar OjaimiImmunology Laboratory, Monash Health, Melbourne, Victoria, Australia.ORCID 0000-0003-2129-1866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChromosome 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome, typically presenting in neonates with congenital cardiac anomalies, hypocalcaemia and thymic hypoplasia. Some patients are diagnosed later in adolescence and adulthood, with less known about the clinical phenotype of these patients.

aimTo summarise key clinical features in cases of 22q11DS diagnosed during adolescence and adulthood.

methodsThis is a retrospective cohort study of 22q11DS patients diagnosed after 13 years of age over 2010-2021, with a literature review of published cases highlighting other late diagnoses. The study was performed in a large multicentre tertiary health network in Melbourne, Australia. Patients diagnosed with 22q11DS after the age of 13 years were included in the study. Main outcome measures were key clinical features in cases of late diagnosis of 22q11DS.

resultsA literature search yielded 53 published case reports and one cohort study for review (62 subjects). Additionally, 10 cases of late diagnosis of 22q11DS were identified through a retrospective electronic medical chart review. Findings suggest that intellectual disability and learning difficulties, hypocalcaemia with hypoparathyroidism and facial dysmorphism remain key features in patients with a late diagnosis of 22q11DS, with hypocalcaemia being the most common presentation leading to diagnosis. Patients diagnosed in adulthood may lack classical clinical features of congenital cardiac anomalies and thymic hypoplasia. Immunological consequences of 22q11DS are also an important late-onset consideration. Atypical features may include basal ganglia calcification.

conclusionsChromosome 22q11DS has diverse clinical features and a highly variable phenotype, likely contributing to underdiagnosis and later diagnoses.

Indexed as

Delayed DiagnosisPhenotype22q11 Deletion SyndromeAdolescentAdultAustraliaDiGeorge SyndromeFemaleHumansHypocalcemiaHypoparathyroidismMaleRetrospective StudiesYoung Adult22q11 deletion syndromeDiGeorge syndromehypoparathyroidismintellectual disabilitylate diagnosis

Identifiers

PMID39425634
PMCPMC11610662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.